Objective. Dysregulated chemokine signaling contributes to autoimmune diseases by facilitating aberrant T cell infiltration into target tissues, but the specific chemokines, receptors, and T cell populations remain largely unidentified. The aim of this study was to examine the role of the potent chemokine CXCL12 and its receptor CXCR4 in the T cell autoimmune response, using alymphoplasia (aly)/aly mice, a model of Sj€ ogren's syndrome (SS).
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Objective. Dysregulated chemokine signaling contributes to autoimmune diseases by facilitating aberrant T cell infiltration into target tissues, but the specific chemokines, receptors, and T cell populations remain largely unidentified. The aim of this study was to examine the role of the potent chemokine CXCL12 and its receptor CXCR4 in the T cell autoimmune response, using alymphoplasia (aly)/aly mice, a model of Sj€ ogren's syndrome (SS).
Methods. T cell phenotypes in the salivary gland of aly/aly mice were evaluated using immunologic analysis. An in vitro migration assay was used to assess T cell migratory activity toward several chemokines. Gene expression of chemokine receptors and transforming growth factor b receptors (TGFbRs) was measured by quantitative reverse transcription-polymerase chain reaction. The CXCR4 antagonist AMD3100 was administered to the aly/aly mice in order to evaluate its suppressive effect on autoimmune lesions.
Results. Effector memory T (TEM) cells derived from aly/aly mice demonstrated higher in vitro migratory activity toward CXCL12 than did TEM cells from aly/+ mice. CXCL12 expression was specifically upregulated in the SS target cells of aly/aly mice. TEM cells from RelB À/À mice, but not Nfkb1 À/À mice, also showed high migratory activity toward CXCL12, implicating a role of the nonclassical RelB/NF-jB2 pathway in the regulation of TEM cell migration. TEM cells from aly/aly mice also overexpressed TGFbR type I (TGFbRI) and TGFbRII. The CXCR4 antagonist AMD3100 suppressed autoimmune lesions in aly/aly mice by reducing TEM cell infiltration.
Conclusion. Our results suggest that the RelB/ NF-jB2 pathway regulates T cell migration to autoimmune targets through TGFb/TGFbR-dependent regulation of CXCL12/CXCR4 signaling. This suggests that these signaling pathways are potential therapeutic targets for the treatment of autoimmune diseases.
Chemokines are important activators of adhesion molecules and drivers of lymphocyte migration to sites of inflammation, including autoimmune lesions. Activated or autoreactive T cells derived from naive T cells migrate to and attack self tissue or cells during initiation of autoimmunity (1, 2) . T cell migration, differentiation, and effector activity are controlled by several chemokines, including CXCL9, CXCL10, CXCL11, and CXCL12 (2-6). However, because T cells dynamically express multiple chemokine receptors, and chemokine binding overlaps among these receptors, the precise mechanisms of T cell regulation by chemokine/chemokine receptor signaling remain unclear.
Among these chemokines, CXCL12 is a critical regulator of tissue homeostasis, immune surveillance, and inflammatory responses (7) . CXCL12 can bind to 2 receptors on T cells, CXCR4 and CXCR7. Moreover, CXCR7 directly modulates CXCR4 signaling via CXCR7/CXCR4 heterodimerization (7) . When CXCL12 binds to CXCR4 on T cells, CXCR4 heterodimerizes with the T cell receptor to stimulate multiple phospholipase C isoforms, increasing the intracellular calcium concentration and activating the ERK pathway, thereby initiating the transcription of genes associated with specific T cell functions (8) . In cancer cells, the expression of CXCR4 and CXCR7 is regulated by NF-jB (9), but it is unclear how cytokine receptor expression in peripheral T cells is controlled.
NF-jB plays a key role in the regulation of many inflammatory processes of immune cells (10) . The NF-jB family consists of 5 subunits: NF-jB1 (p105Àp50), NF-jB2 (p100Àp52), RelA (p65), RelB, and c-Rel. Heterodimers or homodimers of these subunits can be translocated into the nucleus to bind NF-jB sequences neighboring target genes (11) . Two NF-jB signaling pathways exist in the immune cells: a "classical" pathway initiated by the NF-jB1ÀRelA complex, and an alternative "nonclassical" pathway initiated by the NF-jB2ÀRelB complex (11) . The importance of NF-jB-inducing kinase (NIK) in NF-jB activation has been demonstrated in studies using NIKdeficient and alymphoplasia (aly)/aly mice (12) (13) (14) (15) .
The aly/aly mouse carries a mutation in the MAP3K-14/NIK gene. MAP3K-14/NIK is key in regulating the processing of p100 to p52 through IKKa in hematopoietic cells (12) (13) (14) (15) . In addition, aly/aly mice exhibit autoimmune lesions in the lacrimal and salivary glands, resembling those observed in patients with Sj€ ogren's syndrome (SS) (16) . We previously reported that the abnormal activation of naive Tcells, but not effector memory T (TEM) cells, in aly/aly mice contributes to the onset of autoimmunity due to impaired crosstalk between the NF-jB subunits (17) . However, the precise role of NIK in TEM cell function remains unclear. In particular, although the chemokine-dependent migration of TEM cells to the target organs of autoimmunity via the NF-jB2 signaling pathways, including NIK, is a key mechanism in the development of autoimmunity, the precise contribution of NIK remains to be explored.
The heterogeneity of memory T cells depends on the surface molecule expression profile, effector function, signal transduction, and location (18, 19) . Three distinct subsets of memory T cells have been identified: central memory T cells, TEM cells, and memory stem T cells (20) . Central memory T cells express CD62L (also known as L-selectin) and CCR7 (20) , whereas TEM cells do not (20, 21) . The precise migratory function of TEM cells to the target organ in autoimmunity needs to be explored.
In the current study, we focused on the migratory response of T cells to chemokines in aly/aly mice and the molecular mechanism underlying the expression of chemokine receptors. To our knowledge, the current study is the first to indicate a role of NF-jB2 signaling in TEM cell function and in the pathogenesis of autoimmune diseases.
MATERIALS AND METHODS
Mice. The aly/aly and aly/+ mice were obtained from CLEA Japan. Nfkb1 À/À and RelB À/À mice were obtained from The Jackson Laboratory; the genetic background of these mice is C57BL/6J. The mice were housed in a pathogen-free environment within the animal facility at Tokushima University. Mice that were 6À16 weeks of age were used in the study, and all animal experiments were conducted according to the Fundamental Guidelines for Proper Conduct of Animal Experiment and Related Activities in Academic Research Institutions under the jurisdiction of the Japan Ministry of Education, Culture, Sports, Science and Technology. The protocol was approved by the Committee on Animal Experiments at the University of Tokushima, Biological Safety Research Center (permit no. T27-7). All experiments were performed after administering anesthesia, and all efforts were made to minimize suffering in the mice.
Histologic analysis. Salivary glands and lacrimal glands were harvested from the mice and fixed in 10% phosphate buffered formaldehyde (pH 7.2). Histologic examination was performed using sections stained with hematoxylin and eosin.
Immunofluorescence staining and immunohistochemical analysis. Frozen sections of salivary gland tissue were fixed with methanol/acetone (1:1), blocked using a biotinavidin blocking kit (Vector) and 5% bovine serum albumin, and stained with biotinylated anti-mouse CD4 monoclonal antibody (mAb) (RM4.5; eBioscience), with Alexa Fluor 546-conjugated streptavidin (Invitrogen) as the second antibody. In addition, to detect CXCL12 expression in frozen lacrimal gland tissue, anti-CXCL12 polyclonal antibody (anti-stromal cell-derived factor 1a [anti-SDF-1a]) (Abcam), phycoerythrin (PE)-conjugated anti-mouse epithelial cell adhesion molecule (CD326) mAb (G8.8; eBioscience), PE-conjugated anti-CD45.2 (Ly5.2) mAb (104; BioLegend), and biotinconjugated anti-PE mAb (eBioPE-DLF; eBioscience) as the second antibody were used. After washing 3 times with phosphate buffered saline (PBS), nuclear DNA was stained with DAPI (Invitrogen). The sections were observed using a PASCAL confocal laser scanning microscope (LSM) (Zeiss) at 4009 or 6309 magnification. Zeiss LSM image browser version 3.5 was used for image acquisition. For immunohistochemical analysis, paraffin-embedded sections using the tissue specimens fixed in 10% phosphate buffered formaldehyde (pH 7.2) were stained with anti-CXCL12 polyclonal antibody (Abcam) using biotinÀavidin immunoperoxidase complex reagent (Dako) and a DAB (diaminobenzidine) Chromogen Kit (Dako). The nuclei were counterstained with hematoxylin.
Enzyme-linked immunosorbent assay (ELISA). The serum concentration of CXCL12 in B6, aly/+, and aly/aly mice was measured using mouse CXCL12/SDF-1a Quantikine ELISA kit (R&D Systems). Briefly, 96-well flat-bottomed plates were precoated with capture antibodies, and diluted samples of standard recombinant CXCL12 were added to each well. After the plates were washed, biotinylated antibodies were added, and the wells were incubated with horseradish peroxidase-labeled streptavidin. A solution of o-phenylenediamine (OPD; Sigma-Aldrich) was added to each well as the substrate. The optimal density at 490 nm was measured using a microplate reader (model 680; Bio-Rad).
Cell isolation. Spleen cells were suspended by homogenization, and red blood cells were removed with 0.83% ammonium chloride. The remaining cells were washed twice with 2% fetal bovine serum-Dulbecco's modified Eagle's medium. CD44
high CD62LÀ TEM cells and CD44 low CD62L+ naive CD4+ T cells were isolated using a cell sorter (JSAN Jr Swift; Bay Bioscience). The specific subset of the isolated cells was confirmed by evaluation of CCR7 expression (CCR7À for TEM cells, CCR7 low for naive cells). Lymphocytes infiltrating into the target organs were isolated by dispersing lacrimal gland and salivary gland tissue specimens with 1 mg/ml collagenase solution (Wako), followed by density-gradient centrifugation using Histopaque 1083 (Sigma-Aldrich).
Flow cytometric analysis. Lymphocytes from the spleen and target organs were stained using PE-Cy7-conjugated antimouse CD4 mAb (GK1.5; Tonbo Biosciences), fluorescein isothiocyanate-conjugated anti-mouse CD8 mAb (53-6.7; eBioscience), PE-Cy5.5-conjugated anti-mouse CD44 mAb (IM7; Tonbo Biosciences), allophycocyanin (APC)-Cy7-conjugated anti-mouse CD62L mAb (Mel-14; BioLegend), PE-conjugated anti-mouse/human CXCR7 mAb (8F11-M16; BioLegend), biotinylated anti-mouse CXCR4 mAb (2B11; eBioscience), biotinylated anti-mouse CCR7 mAb (4B12; eBioscience), APC-conjugated anti-mouse transforming growth factor b receptor type I (TGFbRI) mAb (141231; R&D Systems), APCconjugated anti-mouse TGFbRII polyclonal antibody (R&D Systems), and APC-conjugated streptavidin (eBioscience). A FACScan flow cytometer (BD Biosciences) was used to identify the cell populations according to the surface expression profile. Flow cytometry data were analyzed using FlowJo software (Tree Star).
In vitro chemotactic migration assay. After serum starvation in RPMI 1640 medium for 24 hours, CD4+ T cells were plated (5 9 10 5 cells in 350 ll) in the culture plate inserts (3.0-lm pore size) (Merck/Millipore). An equal volume of medium containing CXCL9, CXCL10, CXCL11, and CXCL12 (0À750 ng/ml) (R&D Systems) was added to the lower chamber in 350 ll of RPMI 1640 containing 0.1% bovine serum low CD62L+ naive CD4+ cells in the spleens and salivary glands of aly/aly mice and aly/+ mice. Values are the mean AE SD (n = 6-8 mice per group). * = P < 0.05.
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albumin, and then the cells were cultured for 4 hours at 37°C. The number of migrated cells was analyzed by flow cytometry. Quantitative reverse transcription-polymerase chain reaction (qRT-PCR). Total RNA was extracted from lymphocytes using an RNeasy Mini Kit (Qiagen) and subsequently reverse-transcribed into complementary DNA. Threshold cycle (C t ) values of >35 cycles were discarded. For standardization, the C t cutoff in all analyses was set at the default setting (0.2). The expression of messenger RNAs (mRNAs) encoding CXCR4, CXCR7, CXCL12, TGFbRI, TGFbRII, TGFbRIII, b-actin, and GAPDH was determined using a PTC-200 DNA Engine cycler (Bio-Rad) with SYBR Premix Ex Taq reagent (Takara). The primer sequences used were as follows: CXCR4, forward To confirm the specificity of the primers, each PCR product was electrophoresed on an agarose gel to determine the DNA size (in basepairs), and a single band for each product was detected at the expected size. Relative mRNA expression of each transcript was normalized against b-actin mRNA. To confirm the normalization by b-actin, the mRNA expression of CXCL12 was quantified using GAPDH as another housekeeping gene. Samples in each experiment were analyzed in triplicate. The qRT-PCR experiments were repeated at least 3 times.
Administration of AMD3100. The CXCR4 inhibitor AMD3100 (5 mg/kg) (Sigma) was administered daily to female aly/aly mice ages 8-16 weeks, by intraperitoneal injection. As a control, PBS was administered to aly/aly mice according to the same regimen.
Statistical analysis. Group means were compared using Student's unpaired t-test. P values less than 0.05 were considered significant.
RESULTS
TEM cells in the autoimmune lesions of aly/aly mice. Inflammatory lesions in the salivary glands of aly/ aly mice were observed from~10 weeks of age, as previously described (16) . Infiltration of mononuclear cells around dilated ducts and the destruction or atrophy of acinar cells were observed in the salivary gland tissues harvested from 3-month-old aly/aly mice ( Figure 1A) . Moreover, to evaluate the dysfunction of target organs, the flow volume of tears and saliva was measured. The flow in aly/aly mice was significantly lower than that in aly/+ mice with respect to the autoimmune lesions in target organs. Immunofluorescence analysis revealed that CD4+ T cells were the predominant infiltrating cell type ( Figure 1B) , and flow cytometric analysis of isolated salivary gland lymphocytes confirmed that >80% were CD4+ T cells (Figures 1C and D) . The number of CD44 high CD62LÀCD4+ TEM cells was higher in the spleens of aly/aly mice than that in the spleens of aly/+ mice ( Figure 1E ), while there was no difference between aly/aly and aly/+ mice in the total number of TEM cells and the number and proportion of CD44 low CD62L+ naive CD4+ T cells in the spleen (Figures 1E and F) . In contrast, the numbers of both TEM cells and naive T cells in the salivary glands of aly/aly mice were significantly increased compared with the numbers in aly/+ mice ( Figure 1F) .
Enhanced migratory response of aly/aly mouse CD4+ T cells to CXC chemokines. To examine whether the facilitation of migratory activity contributes to the TEM cell infiltration observed in aly/aly mice, the migratory response of CD4+ T cells isolated from aly/aly and aly/+ mouse spleens toward CXCL9, CXCL10, CXCL11, and CXCL12 was evaluated by in vitro Transwell migration assay. The migratory rates of aly/aly mouse CD4+ TEM cells toward CXCL12 were significantly higher than those of aly/+ mouse TEM cells, while there was no difference in the migratory response to CXCL9, CXCL10, and CXCL11 (Figure 2A) . Furthermore, the response increased with increasing CXCL12 concentrations ( Figure 2C ). In contrast, no migratory response toward any of these cytokines was observed with respect to CD4+ naive T cells isolated from aly/aly and aly/+ mouse spleens (Figures 2B and D) .
Elevated CXCL12 expression in the target tissue of aly/aly mice. We measured the serum concentration of CXCL12 by ELISA to examine whether a higher serum concentration contributes to greater TEM cell migration/infiltration in aly/aly mice but observed no difference between the B6, aly/+, and aly/aly mice ( Figure 3A) . We then examined whether local accumulation of CXCL12 in the spleen or target organs is responsible for this enhanced migratory capacity of aly/ aly mouse TEM cells by measuring CXCL12 mRNA expression with qRT-PCR. CXCL12 mRNA expression in the salivary glands and lacrimal glands of aly/aly mice was significantly higher than that in the salivary glands and lacrimal glands of aly/+ mice ( Figure 3B ), but there was no difference in CXCL12 mRNA expression in the spleen and lung ( Figure 3B ). These findings suggest that increased CXCL12 expression in the target tissues (salivary gland and lacrimal gland) contributes to the higher TEM cell accumulation and the consequent autoimmune response.
It is known that increased chemokine levels are detectable in the inflamed tissues of SS patients (22, 23) , and CXCL12 is ubiquitously expressed in many tissues and cell types (7) . To determine the cell type producing CXCL12 in the target organs, we performed immunofluorescence analysis. CXCL12-expressing cells were analyzed in the target tissues of aly/aly mice at 12 weeks of age. Epithelial cell adhesion molecule-positive epithelial cells in lacrimal glands expressed CXCL12 in aly/aly mice, but not aly/+ mice, while CD45.2+ lymphocytes infiltrated into lacrimal glands did not express CXCL12 in aly/aly mice ( Figures 3C and D) . CXCL12 expression was observed in the epithelial cells neighboring the area of lymphocyte infiltration (Figures 3C and D) . At 6 weeks of age, when inflammatory lesions were absent, there was no difference in CXCL12 expression in the lacrimal glands of aly/aly mice and aly/+ mice, suggesting that CXCL12 expression by target cells increases along with the migration of inflammatory cells including T cells, and that T cell migration may further increase following up-regulation of CXCL12, leading to the development of severe autoimmune lesions. Although the precise mechanism underlying CXCL12 up-regulation in the target organs in aly/aly mice remains unclear, the production might be enhanced in the inflammatory lesions of target organs in aly/aly mice.
Elevated CXCL12 receptor expression on TEM cells from aly/aly mice. Although CXCR4 is the best described CXCL12 receptor, this chemokine also binds to CXCR7 (7, 24) . To examine whether the up- regulation of these receptors also contributes to enhanced CXCL12-dependent tissue infiltration of TEM cells in aly/aly mice, CXCR4 and CXCR7 expression in TEM cells and naive T cells isolated from mouse spleens were measured by flow cytometry. Surface expression of CXCR4 on the TEM cells of aly/aly mice was significantly higher than that on TEM cells from aly/+ mice, whereas no difference in the expression of CXCR7 was seen ( Figure 4A ). In contrast, there was no difference between aly/aly mice and aly/+ mice in CXCR7 or CXCR4 expression on naive CD4+ T cells ( Figure 4B ). Furthermore, CXCR4 mRNA expression was significantly higher in TEM cells isolated from the spleens of aly/aly mice compared with that in TEM cells from aly/+ mice, while there was no difference in CXCR7 mRNA expression ( Figure 4C) . No difference between aly/aly mice and aly/+ mice in CXCR7 and CXCR4 expression in naive CD4+ T cells was observed ( Figure 4D ). These findings suggest that the high migratory activity of TEM cells from aly/aly mice toward CXCL12 results from increased expression of CXCR4.
To understand the role of both classical and nonclassical NF-jB pathways in the migratory response of TEM cells to CXCL12, an in vitro migratory assay in response to CXCL12 was performed using TEM cells and naive CD4+ T cells isolated from wild-type (WT), Nfkb1 (p50) À/À , aly/aly, and RelB À/À mice. There was no difference in the migratory response of TEM cells in WT and Nfkb1 À/À mice ( Figure 4E ). In contrast, RelB À/À mice demonstrated a significantly increased migratory response without CXCL12 compared with the WT mice ( Figure 4E ). In addition, the migratory response to CXCL12 in RelB À/À mice was significantly higher than that in the WT mice ( Figure 4E) . Moreover, the migratory response to CXCL12 in RelB À/À mice was significantly higher than that in the aly/aly mice ( Figure 4E) . Therefore, TEM cells in RelB À/À mice are generally more sensitive to chemokines. In accordance with these results, no substantial migratory response was observed with respect to the naive T cells in Nfkb1
, aly/aly, and RelB À/À mice ( Figure 4F ). This suggests that the nonclassical RelB/NF-jB2 pathway regulates the migratory response to CXCL12 in TEM cells.
Role of TGFb1 in CXCR4 expression by TEM cells. TGFb is considered as being the master regulator of T cell activity, and CXCR4 expression in human T cells is controlled by TGFb1 (25, 26) . Therefore, we , aly/aly, and RelB À/À mice (age 10 weeks). Values are the mean AE SD of triplicate determinations (n = 5-7 mice per group). Each experiment was repeated 3 times. * = P < 0.05; ** = P < 0.005. MFI = mean fluorescence intensity (see Figure 1 for other definitions).
examined whether TGFb1 signaling is involved in CXCR4 overexpression by TEM cells from aly/aly mice. TGFb1 up-regulated the expression of CXCR4 mRNA in both aly/aly and aly/+ mouse TEM cells, but the increase was greater in TEM cells from aly/aly mice ( Figure 5A ). In contrast, no enhancement of CXCR4 mRNA expression by TGFb1 was observed in naive CD4+ T cells of either genotype ( Figure 5A ). Moreover, the levels of CXCR4 protein expression on TEM cells from aly/aly mice increased significantly in response to TGFb1, whereas an increase in CXCR4 protein expression on TEM cells from aly/+ mice was not observed ( Figure 5B ). CXCR4 expression in naive T cells in response to TGFb1 in both aly/aly and aly/+ mice did not change ( Figure 5B ). Consistent with a critical role of CXCL12/CXCR4 signaling during increased aly/aly mouse TEM cell migration, the migratory response of TEM cells from aly/aly mice to CXCL12 was further up-regulated by TGFb1 compared with aly/+ mouse TEM cells ( Figure 5C ). Collectively, these results suggest that NF-jB2 negatively controls CXCR4 expression through TGFb signaling. We also investigated whether TGFbR signaling is up-regulated in TEM cells from aly/aly mice, thereby accounting for the enhanced sensitivity to TGFb. Indeed, qRT-PCR results showed that the expression of TGFbRI and TGFbRII was significantly higher in aly/aly mouse TEM cells than in aly/+ mouse TEM cells ( Figure 5D ). As expected, there was no difference in the expression of TGFbRI and TGFbRII in naive CD4+ T cells in aly/+ and aly/aly mice, which again is consistent with the lack of TGFb effects on migration ( Figure 5D ). There was also no difference in TGFbRIII expression in aly/+ and aly/aly mouse TEM cells ( Figure 5D ). Furthermore, flow cytometric analysis revealed that the number of TGFbRI-positive TEM cells in aly/aly mice was significantly higher than that in aly/+ mice ( Figure 5E ). The proportion of TGFbRII-positive TEM cells in aly/aly mice also was increased compared with that in aly/+ mice ( Figure 5F ). These findings suggest that NF-jB2 controls the migratory function of TEM cells by regulating the TGFb/TGFbR/CXCR4 signaling axis.
Therapeutic effect of CXCR4 inhibitor on autoimmune lesions in aly/aly mice. Finally, we examined whether the suppression of migration-promoting signaling pathways reduces the autoimmune response in aly/aly mice. Intraperitoneal injection of the specific CXCR4 antagonist AMD3100 into aly/aly mice from 8 to 16 weeks of age dramatically reduced the infiltrating cell number and the severity of the lesions in the salivary glands and lacrimal glands and suppressed lymphocyte infiltration into these target organs ( Figures 6A  and B) . Moreover, the proportion of TEM cells among all infiltrated lymphocytes in salivary glands and lacrimal glands was significantly reduced by AMD3100 compared with that in the vehicle-treated controls (Figures 6C and D) . There were no differences in the number of CD3+ T cells, CD19+ B cells, CD4+ T cells, and CD8+ T cells in the spleens of mice treated with AMD3100 or vehicle. This suggests that inhibition of CXCR4 prevents autoimmune lesions in aly/aly mice by suppressing CXCL12-induced TEM cell migration.
DISCUSSION
In this study, the phenotype of the CD4+ T cells infiltrating into the target tissues of aly/aly mice was similar to that of CD44 high CD62LÀCCR7ÀCD4+ TEM cells. These infiltrating cells are believed to involve autoreactive T cells. Our findings strongly suggest that CXCL12 is a critical factor promoting TEM cell infiltration into target organs. The migratory response of TEM cells, including autoreactive T cells, was markedly enhanced in aly/aly mice compared with aly/+ mice. Several studies have demonstrated that chemokines are up-regulated in the target organs of patients with SS (22, 27) , and indeed, CXCL12 expression increased in the inflammatory lesions of aly/aly mice. Moreover, CXCR4 was also up-regulated in TEM cells from aly/ aly mice, thus explaining the strong recruitment of these cells into target tissue.
CXCR4 is one of several chemokine receptors exploited by HIV to infect CD4+ T cells, in addition to SDF-1, a major receptor of CXCL12 (28) . CXCR4 is widely expressed at high levels in various immune cells, such as monocytes, B cells, and naive T cells (5, 8, 29, 30) . CXCR4-knockout mice have the embryonic lethality phenotype due to impaired hematopoiesis, organ vascularization, and neuronal migration (29, 31) . Recent studies have demonstrated that blocking the CXCL12ÀCXCR4 interaction can inhibit tumor growth by reducing tumor angiogenesis (5, 24) . Furthermore, inhibition of the CXCL12/CXCR4 pathway in the CD4+ T cells of NOD mice using the specific CXCR4 antagonist AMD3100 can protect against autoimmune diabetes (32) . Similarly, administration of AMD3100 reduced the severity of autoimmune lesions in an experimental model of autoimmune encephalomyelitis by reducing the number of immune cells localizing to the perivascular space in response to CXCL12 (33) . The severity of autoimmune collagen-induced arthritis in interferon-c receptor-deficient DBA/1 mice was reduced by AMD3100 treatment through inhibition of CXCR4+ macrophage migration to the target organs (34) . Moreover, autoimmune thyroiditis in NOD.H-2 h4 mice was also suppressed by AMD3100 treatment (35) .
In the current study, the autoimmune lesions in aly/aly mice were suppressed by AMD3100 treatment via inhibition of TEM cell migration to the target organs. In humans, expression of CXCR4 by naive T cells is controlled by TGFb signaling (26) , and we observed that CXCR4 mRNA expression by TEM cells was also enhanced by TGFb1. Furthermore, the enhancement was strong in TEM cells from aly/aly mice, which is consistent with the enhanced expression of TGFbR. Collectively, these results suggest that NF-jB2 may control CXCR4 expression in TEM cells through TGFb signaling.
NIK plays a key role in regulating the processing of p100 to p52 through IKKa in both hematopoietic cells and osteoclasts (10, 11, 36, 37) . NIK-deficient and aly/aly mice lack lymph nodes, and, at least in aly/aly mice, the T cells show defective proliferation and interleukin-2 production in response to stimulation by the CD3 antibody (anti-CD3) (13) . Furthermore, NIK may be involved in the maintenance of central tolerance in the thymus (14) . Moreover, aly/aly mice and RelB -/-mice show signs of autoimmune disease (16, 38) . A previous study by our group demonstrated that NF-jB2 controls the classical NF-jB pathway in naive CD4+ T cells by interacting with NF-jB1 (17) . In addition, overactivation of naive T cells in aly/aly mice due to impaired interaction with NF-jB2 results in induction of the autoimmune reaction (17) . In the current study, NF-jB2 negatively regulated TGFb signaling in TEM cells, while TGFb up-regulated CXCR4 expression. It is known that a molecular interaction between NF-jB2 and Smad3 downstream of TGFbR plays an important role in the transcriptional activity of c-Jun (39) . Further analysis of the molecular mechanisms controlling CXCR4 expression through NF-jB2 and TGFb signaling is necessary for understanding how T cells contribute to the pathogenesis of autoimmunity.
Therapy for SS, such as sialagogue or moisturizing agents for dry mouth and eye drops for dry eye, is mainly symptomatic (40) . Cytokine or steroid therapy is often effective for some autoimmune diseases such as rheumatoid arthritis. However, a radical therapy for SS has not been established. In aly/aly mice, autoimmune lesions were promoted by up-regulation of both CXCL12 in the target organs and CXCR4 expression on TEM cells. Further study is required to determine the underlying mechanisms of specific CXCL12 overexpression by target tissue but not nontarget tissue such as lung. Inhibiting TEM cell function, including that of autoreactive T cells, may be promising for the treatment of autoimmune disease. AMD3100 suppresses the growth of several malignancies, such as prostate cancer and acute myeloid leukemia, by inhibiting the CXCR4/ CXCL12 axis in tumor stroma (41, 42) . Our study identifies numerous potential molecular targets for such interventions.
In conclusion, the migratory response of TEM cells to CXCL12 was enhanced in aly/aly mice through increased expression of CXCR4 on TEM cells and CXCL12 in target tissues. Up-regulation of CXCL12 in the salivary glands and lacrimal glands suggests that target organs contribute to the initiation of autoimmunity. Inhibition of CXCL12/CXCR4 signaling in TEM cells could be a useful therapeutic strategy for treating SS. Moreover, CXCR4 expression is regulated by NF-jB2 through TGFb signaling, which reveals additional targets for the treatment of autoimmune diseases.
